Clinical Trials Logo

Rumination clinical trials

View clinical trials related to Rumination.

Filter by:

NCT ID: NCT06226467 Not yet recruiting - Emotional Distress Clinical Trials

Neurobehavioral Affective Control Training

N-ACT
Start date: April 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test a new cognitive training program to improve emotion regulation in adults. The investigators' primary aim is to determine whether participating in this program addresses two key features of emotion dysregulation associated with psychiatric disorders: (1) emotion-related impulsivity and (2) rumination. The investigators will further evaluate participants' perceived acceptability and feasibility of treatment procedures. Secondarily, the investigators will examine the effects of this cognitive training intervention on psychiatric symptoms and overall functioning. Participants will be asked to complete eight weekly sessions (over two months) involving cognitive training exercises with a "coach", in addition to a baseline assessment before starting the intervention and post-treatment assessment. Each assessment includes a combination of in-person and remote data collection using self-report questionnaires, psychophysiology, and a neuropsychological battery. Participants will also complete one week of ecological momentary assessment before and after the intervention as well as a set of follow-up questionnaires administered remotely six weeks following their final training session. Researchers will compare participants randomly assigned to complete the intervention without delay to a control group of participants randomly assigned to a two-month waitlist before joining the intervention. Before beginning cognitive training, participants in the control condition will complete an additional pre-intervention/post-waitlist assessment, which will follow parallel procedures to the initial baseline assessment.

NCT ID: NCT05980130 Recruiting - Blood Pressure Clinical Trials

Can Rumination-Focused Cognitive Behavioral Therapy Reduce the Risk of Cardio-vascular Disease?

RFCBT-I
Start date: August 15, 2023
Phase: N/A
Study type: Interventional

Many people know that a poor diet, exercise, smoking, and alcohol use cause heart disease. However, a less known factor that increases the risk of heart disease is depression. In addition, heart disease can also make depression worse. Almost half of American adults have some form of heart disease. Patients with low income are at an even greater risk. The circular relation between depression and heart disease raises the question of whether or not there are factors that lead to both. Attacking a factor that affects both depression and heart disease could help prevent them both. One such factor is rumination which is when someone tends to have repeated negative thoughts that loop without end. This loop in turn tears and wears down the body over time, making the person be at risk for heart disease and depression. Rumination-Focused Cognitive Behavioral Therapy (RFCBT) is a tool that targets rumination and, by doing so, reduces the risk for depression. While research has shown RFCBT helps to reduce or stop the loop that leads to depression, this project will further look at the effect of RFCBT on measures of heart health persons with low income.

NCT ID: NCT05617495 Recruiting - Rumination Clinical Trials

Mindfulness-Based fMRI Neurofeedback for Depression

mbNF
Start date: April 10, 2024
Phase: N/A
Study type: Interventional

In the United States, adolescents experience alarmingly high rates of major depression, and gold-standard treatments are only effective for approximately half of patients. Rumination may be a promising treatment target, as it is well-characterized at the neural level and contributes to depression onset, maintenance, and recurrence as well as predicts treatment non-response. Accordingly, the proposed research will investigate whether an innovative mindfulness-based real-time functional magnetic resonance imaging (fMRI) neurofeedback intervention successfully elicits change in the brain circuit underlying rumination to improve clinical outcomes among depressed adolescents.

NCT ID: NCT05590741 Recruiting - Depression Clinical Trials

An Idiographic Examination of Treatment Mechanisms in Emotion Regulation Therapy

Start date: November 16, 2022
Phase: N/A
Study type: Interventional

This study is an open trial designed to examine individual changes that occur before, during, and after 12 sessions of Emotion Regulation Therapy (ERT) delivered via telehealth for individuals in New York State who are experiencing elevated worry, rumination, or self-criticism.

NCT ID: NCT05589116 Completed - Resilience Clinical Trials

An Online Compassionate Imagery Intervention for Veterinarian Mental Health

Start date: November 29, 2022
Phase: N/A
Study type: Interventional

This randomised control trial aims to determine the efficacy of a two-week, online compassionate imagery intervention on improving veterinarian mental wellbeing. Participants will be randomly allocated to receive the intervention immediately or after a 10-week study period. Self-report questionnaires will be used at four time points to measure change on a range of psychological variables.

NCT ID: NCT05437705 Recruiting - Anxiety Clinical Trials

Decoding and Modulating Affective Brain States

Start date: April 21, 2023
Phase: N/A
Study type: Interventional

Generating personalized brain signatures of negative emotion along with personalized brain stimulation protocols to disrupt these patterns. We plan to use fMRI and muscle activity data to determine negative affect maps for each participant. We will then try a variety of patterned repetitive transcranial magnetic stimulation sequences while recording fMRI which will be the basis of two sessions of 3-day individualized brain stimulation designed to reduce negative affect.

NCT ID: NCT05390879 Completed - Clinical trials for Stress, Psychological

Influence of Meditation on Stress and Rumination Following Objective Structured Clinical Examination (OSCE)

Start date: May 17, 2022
Phase: N/A
Study type: Interventional

Stress and rumination are linked with the development of many mental disorders. The ECOSTRESS study has shown that poor OSCE performance has a positive effect on the occurence of state-rumination among 4th year medicine students in the context of mock exams. The goal of IMSR study is to assess the effectiveness of a post-OSCE meditation intervention to decrease psychological stress and rumination.

NCT ID: NCT05353231 Recruiting - Mental Health Issue Clinical Trials

Brief Mental Training and Internal Attentional Control

Start date: May 23, 2022
Phase: N/A
Study type: Interventional

Previous research documented that real-time feedback on attention as well as related forms of mental training (e.g. mindfulness meditation) may be used to train and impact external attentional control. These approaches to mental training are designed to train meta-awareness in order to enable attentional control. It is not yet known, however, whether such training targeting meta-awareness can be similarly used to impact internal attentional control. Thus, the investigators will test whether real-time feedback training and a brief mindfulness meditation training, relative to placebo control, will lead to greater internal attentional control among adults with elevated negative repetitive thinking.

NCT ID: NCT05350007 Recruiting - Cancer Clinical Trials

Evaluation of Rumination, Frailty and Tanatophobia in Cancer Patients Over 65 Years of Age

CANFRADE
Start date: May 25, 2022
Phase:
Study type: Observational

The aim of this study is to evaluate tanatophobia and rumination in individuals over 65 years of age receiving cancer chemotherapy and to determine the related factors.

NCT ID: NCT05344820 Recruiting - Cancer Clinical Trials

The Effect of the Art-based Mandala Intervention on the Quality of Life of Cancer Patients Receiving Chemotherapy

ARQULA
Start date: May 19, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to determine the effect of mandala application on fatigue, quality of life, rumination and alexithymia in cancer patients receiving chemotherapy.